NCT00593840 · OUTCOME

Quality of Life (QOL) as Measured by Xerostomia QOL Data

Phase II Trial Evaluating Elimination of Radiation Therapy · Source last updated 2026-07-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: MEAN
Unit: units on a scale
Interval / dispersion: Standard Deviation
Time frame: Median follow-up was 22 months

What was measured

-The Quality of Life (QOL) Evaluation (Swallowing and Dryness Questionnaire) will be used. 20 questions with answers of Strongly Agree to Strongly Disagree. Xerostomia score was scaled for a total xerostomia score from 0 to 100 with 0 being the worst QOL and 100 the best QOL.

Groups in this outcome

Arm 1: IMRT

CTV1 = 66 Gy in 33 fractions CTV2 = 60 Gy in 33 fractions CTV3 = 56 Gy in 33 fractions CTV3 Proto = 56 Gy in 33 fractions

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Arm 1: IMRT	65

Reported measurements

Source class 1

Values in units on a scale · Interval/dispersion: Standard Deviation
Group	Value	Spread	Lower	Upper	Comment
Arm 1: IMRT	39.5584	26.0941	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
spread
26.0941
value
39.5584

denoms

counts
group Id
OG000
value
65
units
Participants

description

dispersion Type

Standard Deviation

groups

description
CTV1 = 66 Gy in 33 fractions CTV2 = 60 Gy in 33 fractions CTV3 = 56 Gy in 33 fractions CTV3 Proto = 56 Gy in 33 fractions
id
OG000
title
Arm 1: IMRT

param Type

MEAN

reporting Status

POSTED

time Frame

Median follow-up was 22 months

title

Quality of Life (QOL) as Measured by Xerostomia QOL Data

type

SECONDARY

unit Of Measure

units on a scale

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice